A modular, enantioselective approach to access the bioactive 7,9-dihydroxy- and 9-hydroxy-7-keto-8,4′-oxyneolignans is disclosed, which employs stereoselective Mitsunobu reactions of enantiopure 2-aryl-1,3-dioxan-5-ols and functionalized phenols. The enantiopure dioxanols are prepared through Sharpless asymmetric dihydroxylation of protected coniferyl or sinapyl alcohols and subsequent benzylidene acetal formation. Through a mix-and-match coupling approach, six of the eight possible erythro-7,9-dihydroxy-8,4′-oxyneolignan enantiomeric natural products (bearing a C-1′ hydroxypropyl chain) were generated following sequential deprotection. Subsequent benzylic oxidation afforded the 7-keto-derivatives, resulting in enantioselective syntheses of each enantiomer of the natural products asprenol B and icariol A1.
No takes yet. Share an insight, caveat, or question.
Benda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: